[Therapy and prognosis of neuroblastoma. Report of 54 cases observed in Switzerland].
D000293:Adolescent; D000367:Age Factors; D001862:Bone Resorption / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004298:Dopamine / Q000652:urine; D005260:Female; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000453:epidemiology; D008297:Male; D009362:Neoplasm Metastasis; D009365:Neoplasm Regression, Spontaneous; D009447:Neuroblastoma / Q000188:drug therapy / Q000453:epidemiology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D012075:Remission, Spontaneous; D013557:Switzerland; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D003520:Cyclophosphamide; D004298:Dopamine
Therapie und Prognose des Neuroblastoms. 54 in der Schweiz beobachtete Fälle.